Genmab reported DKK20.25B in Equity Capital and Reserves for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Agios Pharmaceuticals AGIO:US $ 1721.82M 574.81M
Alexion Pharmaceuticals ALXN:US $ 12416.8M 765.6M
Amarin AMRN:US $ 645.32M 10.71M
Amgen AMGN:US $ 8247M 1087M
AstraZeneca AZN:LN 15676M 1246M
Bayer BAYN:GR € 30389M 4199M
Biomarin Pharmaceutical BMRN:US $ 4241.57M 79.56M
Bluebird Bio BLUE:US $ 984.56M 215.77M
Exelixis EXEL:US $ 2043.08M 131.89M
Fresenius Medical Care FME:GR € 12812M 388M
Galapagos GLPG:NA € 2663.47M 37.99M
Genmab GEN:DC DK 20252M 157M
GlaxoSmithKline GSK:LN 15377M 512M
GN Store Nord GN:DC DK 5874M 31M
GRIFOLS GRF:SM € 5168.17M 254.92M
H. Lundbeck A/S LUN:DC 17.54B 317M
Hikma Pharmaceutical HIK:LN 2.29B 155M
Immunogen IMGN:US $ 68.46M 25.66M
Insmed INSM:US $ 531.05M 329.42M
Lonza Group LONN:SW 7.27B 452M
Merck MRK:GR € 19293M 377M
Novartis NOVN:VX SF 54042M 3519M
Regeneron Pharmaceuticals REGN:US $ 15127.3M 3150.3M
Seattle Genetics SGEN:US $ 3391.27M 33.35M
William Demant Holding WDH:DC 7.76B 486M